1. Home
  2. APGE vs SCL Comparison

APGE vs SCL Comparison

Compare APGE & SCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • SCL
  • Stock Information
  • Founded
  • APGE 2022
  • SCL 1932
  • Country
  • APGE United States
  • SCL United States
  • Employees
  • APGE N/A
  • SCL N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • SCL Package Goods/Cosmetics
  • Sector
  • APGE Health Care
  • SCL Consumer Discretionary
  • Exchange
  • APGE Nasdaq
  • SCL Nasdaq
  • Market Cap
  • APGE 1.8B
  • SCL 1.7B
  • IPO Year
  • APGE 2023
  • SCL N/A
  • Fundamental
  • Price
  • APGE $39.72
  • SCL $55.30
  • Analyst Decision
  • APGE Strong Buy
  • SCL
  • Analyst Count
  • APGE 4
  • SCL 0
  • Target Price
  • APGE $91.33
  • SCL N/A
  • AVG Volume (30 Days)
  • APGE 789.9K
  • SCL 139.6K
  • Earning Date
  • APGE 03-03-2025
  • SCL 04-29-2025
  • Dividend Yield
  • APGE N/A
  • SCL 2.78%
  • EPS Growth
  • APGE N/A
  • SCL 25.71
  • EPS
  • APGE N/A
  • SCL 2.20
  • Revenue
  • APGE N/A
  • SCL $2,180,274,000.00
  • Revenue This Year
  • APGE N/A
  • SCL $6.18
  • Revenue Next Year
  • APGE $795.25
  • SCL $6.39
  • P/E Ratio
  • APGE N/A
  • SCL $25.15
  • Revenue Growth
  • APGE N/A
  • SCL N/A
  • 52 Week Low
  • APGE $29.10
  • SCL $54.89
  • 52 Week High
  • APGE $68.21
  • SCL $94.77
  • Technical
  • Relative Strength Index (RSI)
  • APGE 55.27
  • SCL 33.69
  • Support Level
  • APGE $38.18
  • SCL $56.68
  • Resistance Level
  • APGE $41.07
  • SCL $59.05
  • Average True Range (ATR)
  • APGE 2.31
  • SCL 1.59
  • MACD
  • APGE 0.22
  • SCL -0.05
  • Stochastic Oscillator
  • APGE 63.77
  • SCL 9.12

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. Surfactants are chemical agents that affect the interaction between two surfaces. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. Majority of Stepan's revenue comes from the United States.

Share on Social Networks: